U.S. Republican Sen. Marsha Blackburn of Tennessee this week urged U.S. Food and Drug Administration officials to address shortages of drugs used to treat patients with lupus.
Hydroxychloroquine and chloroquine, used to treat autoimmune diseases like lupus, are currently used to treat COVID-19.
“We should not be facing a choice between treating lupus and COVID-19,” Blackburn said in a statement. Read More
The governor of Nevada barred the use of anti-malaria drugs for outpatient treatment after President Donald Trump said the medication could potentially be used as treatment for COVID-19. Read More
Public affairs strategist and all-star panelist Clint Brewer joined The Tennessee Star Report with Michael Patrick Leahy – broadcast on Nashville’s Talk Radio 98.3 and 1510 WLAC weekdays from 5:00 a.m. to 8:00 a.m. – Wednesday morning on the newsmakers line. Read More
President Donald Trump announced during a Thursday press briefing that the anti-malarial drug chloroquine was approved by the Food and Drug Administration as a possible treatment for the coronavirus.
The announcement comes the day after Breitbart News reported that the medical establishment has known about chloroquine’s effectiveness in treating the virus since at least the 2005 SARS coronavirus outbreak.
“Clinical trials are already underway for many new therapies and we’re working on scaling these to allow many more Americans to access different drugs that have shown really good promise,” President Trump said. Read More
Chloroquine, a common antimalarial drug, has shown promising results in treating COVID-19 coronavirus in South Korea and China, according to a white paper. Read More